• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of infertility in systemic carnitine deficient mouse (JVS mouse)

Research Project

Project/Area Number 10671477
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionThe University of Tokushima

Principal Investigator

MURAKAMI Takashi  The Tokushima University, School of Medicine, Instructor, 医学部, 助手 (40210009)

Co-Investigator(Kenkyū-buntansha) MIYAMOTO Tadayuki  The Tokushima University, Medicine School Hospital, Associate Professor, 医学部・附属病院, 講師
ISHIMURA Kazunori  The Tokushima University, School of Medicine, Professor, 医学部, 教授 (90112185)
KUWAJIMA Masamichi  The Tokushima University, School of Medicine, Associate Professor, 医学部, 助教授 (00205262)
TANAKA Toshihiro  University of Tokyo, Human Genome Center, Instructor, 医科学研究所・ヒトゲノム解析センター, 助手 (50292850)
TOSHIMORI Kiyotaka  Miyazaki Medical College, Professor, 医学部, 教授 (20094097)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 1999: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1998: ¥1,400,000 (Direct Cost: ¥1,400,000)
Keywordscarnitine / carintine transporter / infertility / JVS mouse / octn2 / epidiymis / THP / azoospermia / 精巣上体 / 全身性カルニチン欠乏マウス / 閉塞性無精子症
Research Abstract

Juvenile Visceral Steatosis (JVS) mouse, which we reported in 1991, serves as an animal model of primary carnitine deficiency. Because this mouse is suffered from severe male infertility, we analyzed the cause and mechanism. The summary of the results is as follows ;
1. Analysis of candidate gene
As a human OCTN2 gene encoding a sodium-dependent carnitine cotranspoter was isolated, we isolated the mouse octn2 gene and screened for its mutation in the JVS mouse. DNA sequencing analysis disclosed a missense mutation from CTG (Leu) to CGG (Arg) at codon 352 located within the sixth transmembrane domain of octn2. This amino acid replacement possibly causes the conformational change of the protein that leads to dysfunction of the gene product.
2. Analysis of epididymis
At 8-9 weeks of age, the epididymis was deformed, and its weight was significantly increased. Histologically, the duct of proximal epididymis was dilated due to the accumulation of unusually high level of spermatozoa. Spermatozoa ware extravasated from the epididymal duct into the stroma. In contrast, the duct of the distal epididymis was constricted and contained no spermatozoa. Thus, the epididymal disorder causes obstructive azoospermia, leading to infertility.
3. Discovery of camitine transport inhibitor
The site of action of 3-(2,2,2-trimethylhydrozinium) propionate (THP), a new cardioprotective agent, was investigated in mice and rats. As a result, it was indicated that the principal site of action of THP is the carnitine-transport carrier in kidney but not the carrier in heart.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] M.Kuwajima: "Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency"J.Med.Cell.Candiol.. 30. 773-781 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] N.Hoshimoto: "Gene-Dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transport dificiency"Biochem.Pharmacol. 55. 1729-1732 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K.Lu: "A missense mutation of mouse OCTN2,a sodium-dependent carnitine transporter,in the juvenile visceral steatosis (JVS)mouse"Biochem.Biophs.Res.Commun.. 252. 590-594 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M.Kuwajima: "Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2,2-trimethylhydrazinium)propionate in mice:Inhibiton of carnitine transport in kidney"J.Pharmacol.Exp.Ther.. 289. 93-102 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M.Kuwajima: "Cardiomegaly in the juvenile visceral steatosis(JVS)mouse in reduced with acute elevation of hrart short-chain acyl-carnitine level often L-carnitine injection"FEBS Lett.. 446. 323-326 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Kuwajima: "Characteristics of cardiac hypertorophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency."J. Mol. Cell. Cardiol.. 30. 773-781 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] N. Hashimoto: "Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human caritine tranport deficiency."Biochem. Pharmacol.. 55. 1729-1732 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Lu: "A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis (JVS) mouse."Biochem, Biophys. Res., Commun.. 252. 590-594 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Kuwajima: "Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2,2-trimethlhydrazinium) propionate in mice : Inhibition of carnitine transport in kidney."J. Pharmacol. Exp. Ther.. 289. 93-102 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M. Kuwajima: "Cardiomegaly in the juvenile visceral steatosis (JVS) mouse is reduced with acute elevation of heart short-chain acyl-carnitine level after L-carnitine injection."FEBS Lett.. 443. 261-266 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] K. Toshimori: "Dysfunction of the epididymis as a result of primary carnitine deficiency in animal model juvenile visceral steatosis mice."FEBS Lett.. 446. 323-326 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M.Kuwajima: "Pharmacokimetic analysis of the cardioprotective effect of 3-(2;2,2-trimethylhydrazium) propionate in mice : Inhibition of carnitine transport in kidney"J.Pharmacol.Exp.Ther.. 289. 93-102 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] K.Toshimori: "Dysfunction of the epididymis as a result of primary carnitine deficiency in animal model juvenile visceral steatosis mice"FEBS Lett. 446. 323-326 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] K.Lu: "Amissense mutation of mouse OCTN2,a sodium-dependent carnitine cotranspoter,in the juvenile visceral steatsis(JVS)mouse" Biochem.Biophys.Res.Commun.252. 590-594 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] K.Toshimori: "Dysfunction of the epididymis as a result of primary curnitine deficiency in animal model Juvenile visceral steatosis mice" FEBS Letter. (in press).

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi